LY-3202328
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameLY-3202328
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Apptec Co LtdEli Lilly And Company
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesWuxi Apptec Co Ltd
Inactive CompaniesEli Lilly And CompanyWuxi Apptec(Shanghai) Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A